Abstract:Abstract Background Activation of the complement component 5a (C5a) and nuclear factor κB (NF-κB) signaling is an important feature of myocardial ischemia/reperfusion (I/R) injury and recent studies show that morphine postconditioning (MP) attenuates the myocardial injury. However, the mediating cardioprotective mechanisms remain unclear. The present study explores the role and interaction of heat shock protein 90 (HSP90), Akt, C5a, and NF-κB in MP-induced cardioprotection. Methods Male Sprague Dawley rats ( n = 160) were randomized into eight groups ( n = 20 per group). Rats in the sham group underwent thoracotomy, passing the ligature through the heart but without tying it (150 min), and the other seven groups were subjected to 30 min of anterior descending coronary artery occlusion followed by 2 h of reperfusion and the following treatments: I/R (30 min of ischemia and followed by 2 h of reperfusion); ischemic postconditioning (IPostC, 30 s of ischemia altered with 30 s of reperfusion, repeated for three cycles, and followed by reperfusion for 2 h); MP (0.3 mg/kg morphine administration 10 min before reperfusion); MP combined with the HSP90 inhibitor geldanamycin (GA, 1 mg/kg); MP combined with the Akt inhibitor GSK-690693 (GSK, 20 mg/kg); and MP combined with the C5a inhibitor PMX205 (PMX, 1 mg/kg/day, administration via drinking water for 28 days) and MP combined with the NF-κB inhibitor EVP4593 (QNZ, 1 mg/kg). All inhibitors were administered 10 min before morphine and followed by 2 h reperfusion. Results MP significantly reduced the I/R-induced infarct size, the apoptosis, and the release of cardiac troponin I, lactate dehydrogenase (LDH), and creatine kinase-MB. These beneficial effects were accompanied by increased expression of HSP90 and p-Akt, and decreased expression of C5a, NF-κB, tumor necrosis factor α, interleukin-1β, and intercellular cell adhesion molecule 1. However, HSP90 inhibitor GA or Akt inhibitor GSK increased the expression of C5a and NF-κB and prevented MP-induced cardioprotection. Furthermore, GA inhibited the MP-induced upregulation of p-Akt, while GSK did not affect HSP90, indicating that p-Akt acts downstream of HSP90 in MP-induced cardioprotection. In addition, C5a inhibitor PMX enhanced the MP-induced downregulation of NF-κB, while NF-κB inhibitor QNZ had no effect on C5a, indicating that the C5a/NF-κB signaling pathway is involved in MP-induced cardioprotection. Conclusion HSP90 is critical for MP-mediated cardioprotection possibly by promoting the phosphorylation of Akt and inhibiting the activation of C5a and NF-κB signaling and the subsequent myocardial inflammation, ultimately attenuating the infarct size and cardiomyocyte apoptosis.

Myocardial Apoptosis and Infarction after Ischemia/reperfusion Are Attenuated by Kappa-Opioid Receptor Agonist.

Inhibition of Mitochondrial Permeability Transition Pore Opening Mediated by Kappa‐opioid Receptor in Cardioprotection by Remote Preconditioning

[The Study of Effects and Mechanism of U50, 488H on Electrical Coupling During Ischemia in the Perfused Isolated Rat Heart].

Interaction between opioid receptor and adrenoceptor signaling in ischemia reperfusion of the isolated rat heart

[COX-2 mediates U50488H-induced delayed cardioprotection in isolated rat heart].

Effect of HOE642 on Myocardial Ischemia/reperfusion Injury and Apoptosis

Kappa-Opioid Receptors Mediate Cardioprotection by Remote Preconditioning

Delayed Uncoupling is Related to Cardioprotection Induced by Kappa-Agonist U-50,488H in Rat Heart.

Anti-arrhythmic Effect Mediated by Regulation of Κ-Opioid Receptor Agonist U50,488H on Cx43 is Associated with Inhibition of Calcium Channel

κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a

Knockout of the Tumor Necrosis Factor a Receptor 1 Gene Can Up-Regulate Erythropoietin Receptor During Myocardial Ischemia-Reperfusion Injury in Mice.

CPU0213, a novel endothelin type A and type B receptor antagonist, protects against myocardial ischemia/reperfusion injury in rats

Chronic U50,488h Abolishes Inositol 1,4,5-Trisphosphate and Intracellular Ca2+ Elevations Evoked by Kappa-Opioid Receptor in Rat Myocytes

Abstract 11409: Kappa-opioid Stimulation Following Chronic Cardiac Pressure Overload Increases Endothelial Caveolae Formation and Benefits Cardiac Function

Morphine Reduces Myocardial Infarct Size via Heat Shock Protein 90 in Rodents

The Infarct-Reducing Effect of the δ2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism

Butorphanol Alleviates Hypoxia/Reoxygenation‐Induced Myocardial Injury by Activating Wnt/β‐Catenin Signal Pathway

Effects of nalbuphine on the cardioprotective effect of morphine in rats

New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB

Potent mitochondria-targeted peptides reduce myocardial infarction in rats

Comparative Analysis of Infarct-Limiting Activity of Peptide and Non-Peptide δ- and κ-Opioid Receptor Agonists during Heart Reperfusion In Vivo